Viking Therapeutics
Sort by
1 items
-
Business - MarketWatch
Viking Therapeutics reports positive data from trial of treatment for rare metabolic disorder X-ALD
Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.2 hours ago